EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets

Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, Joey Chan, Emre Derin iD, Hasan Slika iD, Betty Tyler iD

Cells · 19.09.2024 · 13 (18) · 1574

DOI: 10.3390/cells13181574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.09.2024. Verfasst von Ashley Irin Cortes Ballen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunterian Neurosurgical Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khatib Brain Tumor Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is an aggressive and highly malignant primary brain tumor characterized by rapid growth and a poor prognosis for patients. Despite advancements in treatment, the median survival time for GBM patients remains low. One of the crucial challenges in understanding and treating GBMs involves its remarkable cellular heterogeneity and adaptability. Central to the survival and proliferation of GBM cells is their ability to undergo metabolic reprogramming. Metabolic reprogramming is a process that allows cancer cells to alter their metabolism to meet the increased demands of rapid growth and to survive in the often oxygen- and nutrient-deficient tumor microenvironment. These changes in metabolism include the Warburg effect, alterations in several key metabolic pathways including glutamine metabolism, fatty acid synthesis, and the tricarboxylic acid (TCA) cycle, increased uptake and utilization of glutamine, and more. Despite the complexity and adaptability of GBM metabolism, a deeper understanding of its metabolic reprogramming offers hope for developing more effective therapeutic interventions against GBMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansGlutamineCellular ReprogrammingMetabolic Networks and PathwaysTumor MicroenvironmentAnimalsMetabolic Reprogramming

Stichwörter der Autor:innen

Warburg effectglioblastoma multiformeglycolysismetabolic reprogrammingtherapeutic drugstumor microenvironment

Substanzen

Glutamine

Autor:innen und Institutionen

  • Hunterian Neurosurgical Laboratory, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

ORCID-Profile: Emre Derin, Hasan Slika, Betty Tyler

Förderung

  • Khatib Brain Tumor Center

Zitieren

APA

Cortes Ballen, A. I., Amosu, M., Ravinder, S., Chan, J., Derin, E., Slika, H., & Tyler, B. (2024). Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cells, 13(18), 1574. https://doi.org/10.3390/cells13181574

Vancouver

Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H, et al. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cells. 2024;13(18):1574. doi:10.3390/cells13181574

BibTeX
@article{CortesBallen2024,
  author = {Cortes Ballen, Ashley Irin and Amosu, Maryam and Ravinder, Surya and Chan, Joey and Derin, Emre and Slika, Hasan and Tyler, Betty},
  title = {Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {1574},
  doi = {10.3390/cells13181574}
}
Kostenlos starten →